(This user asked anonymously)
Program Officer  |  Bhutan

Choice of journal for publication

Asked: 24 Jun 2019  |   628
Which journal should I go for a publication of research on Economic evaluation of vaccine?

Expert Replies:

Yot Teerawattananon

Senior Researcher  |  Thailand  |   Replied: 19 Jul 2019 at 14:30
If I may, I would like to recommend other two journals i.e. PLOS ONE and F1000. These two open-access journals accept economic evaluation studies (as well as other academic articles) and will publish them based on quality (methodological rigour), not perceived importance (of a paper) to a scientific field. Papers in PLOS ONE need peer-review before publication while paper in F1000 are published first and peer reviewed after publication. Papers in these two journals (after passing the review process for papers in F1000) are indexed in the PubMed and PubMed Central databases.

Alec Morton

Professor  |  United Kingdom  |   Replied: 25 Jun 2019 at 21:03
I agree with Yoel, it depends on the characteristics of the paper and the audience you want to attract the attention of.
Readers of journals like Vaccine, Expert Review of Vaccines and Human Vaccines and Immunotherapeutics will be interested in vaccines in general and will expect that the literature review and discussion and conclusion reflect that interest. Readers of journals of Pharmacoeconomics or Value in Health or (especially) Health Economics will want to see that there is some methodological innovation. You could also go for a general medical journal like BMJ Global Health or PLOS Med, or indeed a more disease-specific journal (like eg the Malaria journal) for the disease against which the vaccine protects.

Yoel Lubell

Professor  |  Thailand  |   Replied: 25 Jun 2019 at 13:43
If the methodology you used or the interventions you're looking at in are in some way new then you could try for health economics journals (e.g. Health Economics or Pharmacoeconomics). If on the other hand the methods are more standard and it's an intervention that is already used elsewhere, and the focus is on the health impact and cost-effectiveness in a particular country then I suggest trying 'Vaccine', BMJ Global Health or Lancet Global Health in the first instance (higher impact but lower probability of acceptance). Failing these are lower impact journals such as Cost-Effectiveness and Resource Allocation (https://resource-allocation.biomedcentral.com/), BMC Public Health, TMIH or AJTMH.

Leave your reply:

Please sign in before leaving a reply.

Expert Profiles

Yot Teerawattananon

Senior Researcher
Health Intervention and Technology Assessment Program (HITAP)

Alec Morton

Professor, University of Strathclyde, Glasgow
Please sign in before asking an expert.